Challenges and tactics for transformative drug development - a podcast by Drug Discovery World (DDW)
from 2023-06-22T14:36
This is the latest episode of the free DDW narrated podcast, “Challenges and tactics for transformative drug development". It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Balancing speed and quality in CLD for faster drug development”, and “Sitting down with BridgeBio Pharma”.
In the first article, Soojin Han, Chief Technical Lead and a Head of R&D at Samsung Biologics America, examines the challenges, tactics, and best partnering practices in cell line development (CLD). She emphasises the need to ensure a balance between shortening commercial CLD timelines, increasing efficiencies and maintaining product quality.
In the second article, Michael Henderson, MD, Chief Business Officer of BridgeBio Pharma, tells Lu Rahman about the company’s pursuit of transformative medicines to treat genetic diseases.
In the third article, FRAME Education and Outreach Manager Amy Beale discusses how current legislative and regulatory requirements for animal research could be strengthened to help prevent animal experiments and accelerate change. She also considers the factors influencing the lack of change within animal research.
Further episodes of The Drug Discovery World Podcast
Further podcasts by Drug Discovery World (DDW)
Website of Drug Discovery World (DDW)